STAT3 and melanoma: In NSCLC, high tumor-infiltrating Th1 cells correlate with poor prognosis, whereas Th17 dominance in melanoma and CRC promotes immunosuppression through IL-6/STAT3 signaling and regulatory T cell (Treg) conversion [30].